Literature DB >> 15354080

A new model of glaucoma filtering surgery in the rat.

M B Sherwood1, D W Esson, A Neelakantan, D A Samuelson.   

Abstract

PURPOSE: The most common reason for long-term failure of glaucoma filtering surgery (GFS) is scarring of the external filtering "bleb" tissues. The identification of the factors that mediate this process, as well as the development and initial testing of new therapies to limit scarring is enhanced by the use of appropriate animal models. The standard animal model for studying GFS is the rabbit but newer investigative tools that examine changes induced in biologic systems at a genetic level have made development of a rat model desirable.
METHODS: Glaucoma filtering surgery was performed on 20 Sprague-Dawley rats by introducing a 30-gauge silicone cannula through a penetrating scleral tunnel, under a limbal-based conjunctival flap and suturing the conjunctiva closed. Identical GFS was performed on 3 additional rats, which underwent histologic evaluation at days 2, 5, and 11, following surgery.Fistulizing surgery was also performed on 6 Sprague-Dawley rats, for comparison, by creating a full-thickness needle sclerostomy under a limbal-based conjunctival flap and suturing the conjunctiva closed.
RESULTS: Following the cannula GFS, well-elevated filtering blebs formed and these gradually failed over the course of 8 to 13 days. Needle tract sclerostomy filtering blebs formed at the site of the fistulizing surgery but rapidly failed over the course of 2 to 3 days.
CONCLUSION: Cannulated filtering surgery in the rat provides a longer lasting and more predictable model than needle tract sclerostomy for studying wound healing following GFS and may facilitate the study of induced changes at the gene level.

Entities:  

Mesh:

Year:  2004        PMID: 15354080     DOI: 10.1097/01.ijg.0000131482.86547.5a

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  12 in total

1.  Prevention of ocular scarring after glaucoma filtering surgery using the monoclonal antibody LT1009 (Sonepcizumab) in a rabbit model.

Authors:  Zachary L Lukowski; Jeff Min; Ashley R Beattie; Craig A Meyers; Monica A Levine; Glenn Stoller; Gregory S Schultz; Don A Samuelson; Mark B Sherwood
Journal:  J Glaucoma       Date:  2013-02       Impact factor: 2.503

2.  Validation of the glaucoma filtration surgical mouse model for antifibrotic drug evaluation.

Authors:  Li-Fong Seet; Wing Sum Lee; Roseline Su; Sharon N Finger; Jonathan G Crowston; Tina T Wong
Journal:  Mol Med       Date:  2011-01-11       Impact factor: 6.354

3.  Exosome-mediated aptamer S58 reduces fibrosis in a rat glaucoma filtration surgery model.

Authors:  Qian-Yi Lin; Xiang-Ji Li; Yu Leng; Xiao-Min Zhu; Min Tang; Yi Lin; Wang-Du Luo; Bing-Cai Jiang; Xia Chen; Lin Xie
Journal:  Int J Ophthalmol       Date:  2022-05-18       Impact factor: 1.645

Review 4.  Gene therapy targeting glaucoma: where are we?

Authors:  Xuyang Liu; Carol A Rasmussen; B'ann T Gabelt; Curtis R Brandt; Paul L Kaufman
Journal:  Surv Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 6.048

5.  Animal models of scarring control.

Authors:  David L Williams
Journal:  Eye (Lond)       Date:  2019-12-10       Impact factor: 3.775

Review 6.  Looking into the future: Gene and cell therapies for glaucoma.

Authors:  András M Komáromy; Kristin L Koehl; Shin Ae Park
Journal:  Vet Ophthalmol       Date:  2021-01-07       Impact factor: 1.644

7.  Prevention of ocular scarring post glaucoma filtration surgery using the inflammatory cell and platelet binding modulator saratin in a rabbit model.

Authors:  Jeff Min; Zachary L Lukowski; Monica A Levine; Craig A Meyers; Ashley R Beattie; Gregory S Schultz; Don A Samuelson; Mark B Sherwood
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

8.  Inhibition by a retinoic acid receptor γ agonist of extracellular matrix remodeling mediated by human Tenon fibroblasts.

Authors:  Yang Liu; Kazuhiro Kimura; Tomoko Orita; Katsuyoshi Suzuki; Shinichiro Teranishi; Takuya Mori; Koh-Hei Sonoda
Journal:  Mol Vis       Date:  2015-12-31       Impact factor: 2.367

9.  Exogenous Tissue Inhibitor of Metalloproteinase-2 Affects Matrix Metalloproteinase-2 Expression in Conjunctival Filtering Blebs and Bleb Scarring in Rats.

Authors:  Ling Wang; Meng-Ying Liu; Gang Yin; Na Li; Da-Bo Wang
Journal:  Biomed Res Int       Date:  2018-05-31       Impact factor: 3.411

10.  Correlation between Tissue Characterization and Dynamic Expression of Matrix Metalloproteinase-2 and Its Tissue Inhibitor in Conjunctival Filtering Bleb of Rats.

Authors:  Ling Wang; Da-Bo Wang; Meng-Ying Liu; Ru-Yong Yao
Journal:  Biomed Res Int       Date:  2017-09-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.